Navigation Links
Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis
Date:9/3/2008

Third Clinical Trial Reconfirms Strong Evidence Pycnogenol(R) Lowers Joint Pain, Symptoms; May Now Have Lasting Effect on Joints Following Cessation

of the Extract

HOBOKEN, N.J., Sept. 3 /PRNewswire/ -- According to the Center for Disease Control (CDC), osteoarthritis, the most common type of arthritis, is on the rise. A new study published in the August journal of Phytotherapy Research, reveals Pycnogenol(R), bark extract from the French maritime pine tree, reduced overall knee osteoarthritis (OA) symptoms by 20.9 percent and lowered pain by 40.3 percent. To date, this is the third clinical trial on osteoarthritis treatment with Pycnogenol(R). This study investigated what happens to joint symptoms after treatment with Pycnogenol is terminated and the results show that no relapse occurred after two weeks. Pycnogenol acts as potent anti-inflammatory and the lasting effects found in this study suggest that Pycnogenol may help the joints to recover.

With osteoarthritis cases on the rise, many are seeking non-traditional medication to help ease the pain and reduce the amount of traditional medication taken. The CDC estimates osteoarthritis affects 34 percent of all adults over the age of 65. In 2005, an estimated 26.9 million adults in the U.S. had osteoarthritis, which was up from 21 million in 1990. While there's no known cure for osteoarthritis, treatments such as nonsteroidal anti- inflammatory drugs (NSAIDs) or analgesics can help reduce pain and also maintain joint movement, to help the quality of life for people living with the disease. In more severe cases, cortisone shots and joint replacement surgery are used to treat OA.

"The current study is in accordance with the two previous Pycnogenol(R) studies for osteoarthritis," said Dr. Peter Rohdewald, one of the researchers of the study. "Again the pain is gradually decreasing during the course of three months treatment with Pycnogenol(R). An improvement is
'/>"/>

SOURCE Natural Health Science Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
2. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
3. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
4. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
5. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
6. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
7. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
8. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study
9. National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
10. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
11. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
(Date:5/23/2013)... , May 23, 2013  Echo Pharma Acquisition ... to waive down the Acceptance Threshold from 90 percent ... one Elan Share in accordance with the terms of ... conditions summarized below. Under the terms of ... Elan (NYSE: ELN ) for $12.50 per ...
(Date:5/23/2013)... PARIS , May 23, 2013  Volcano Corporation ... manufacturer of precision guided therapy tools designed to enhance ... disease, today announced preliminary results from the ADVISE ( ... S tenosis E valuation) II trial during the ... 2013. These prospective results confirm prior retrospective publications, and ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
(Date:5/23/2013)... (PRWEB) May 23, 2013 Visage Imaging ... (ASX: PME), announced today that they have released ... the Apple App Store*. When used in tandem with ... Ease provides authorized healthcare providers simple mobile access to ... devices. , In addition to numerous enhancements and performance ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Registered Dietitian ... published an article today on Tatalou.com offering helpful tips ... , The article, titled “ How to Stay Healthy ... to carry hand sanitizer, when it’s safe to drink ... for seafood, the importance of staying hydrated and how ...
(Date:5/23/2013)... Memorial Day is Monday, May 27, a day that marks ... the nation, people will have picnics, visit loved ones, and ... to those who have experienced the loss of a loved ... Day this year, the U.S. is still involved in conflicts ... men and women remind all Americans that life is precious. ...
(Date:5/23/2013)... York, NY (PRWEB) May 23, 2013 ... New York Supreme Court (reference number 110504/2009) by Lori ... a verdict awarding Ms. Mandel $8.6 million. Ms. Mandel ... whose alleged misdiagnosis led to further complications that affected ... perform her work. , The plaintiff alleged that her ...
(Date:5/23/2013)... May 23 2013 - New techniques in imaging ... from McGill University,s Montreal Neurological Institute, and his ... from epilepsy. The combination of electroencephalogram (EEG) ... more precise localization of the areas generating epileptic ... optimal ways of intervention, if appropriate. These ...
Breaking Medicine News(10 mins):Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:How to Stay Healthy While Traveling 2Health News:Memorial Day: Make it a Time of Remembrance and Support 2Health News:Memorial Day: Make it a Time of Remembrance and Support 3Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New imaging techniques used to help patients suffering from epilepsy 2
... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... 2009 earnings on Monday, April 27, 2009. The Company will ... Time) on that date to discuss these results and other ...
... Ohio An experimental agent has shown promising results ... multi-institutional clinical trial led by cancer researchers at the ... AZD6244 (ARRY-142886), blocks certain enzymes that cancer cells need ... diagnosed with biliary cancer worldwide every year, representing 15-20 ...
... very difficult choices, such as deciding to end life-support for ... Journal of Consumer Research delves into the question of ... make those "tragic choices." , Authors Simona Botti (London ... University) say that from the time of Hippocrates until the ...
... vending machines offer healthy choices these days, so why do ... Journal of Consumer Research shows that some efforts ... have fulfilled a healthy eating goal even if they choose ... among food choices may draw their attention to the least-healthy ...
... WASHINGTON, April 20 Mark Leventhal, Esq., the Founder and ... first in the nation executive weight loss consulting service for ... Angeles County Bar Association, 1055 West 7th Street, 27th Floor, ... in 2009." Mark Leventhal will be talking about ...
... In an unprecedented effort to increase access to ... people with disabilities, President Obama invited CEOs from ... Tobin, United Spinal Association,s President ( www.unitedspinal.org ... briefing on the Administration,s disability policy initiatives, and ...
Cached Medicine News:Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results 2Health News:Targeted agent shows promise in biliary cancer study 2Health News:Tragic choices: Is it better for doctors or patient families to decide? 2Health News:Best intentions: The presence of healthy food can lead to unhealthy choices 2Health News:Mark Leventhal Speaks at the Los Angeles County Bar Association 2Health News:United Spinal Association Joins National Disability Leaders for Historic Meeting at the White House 2
The major innovation in posterior stabilized (PS) knee design. Improve patellofemoral kinematics. Reduce wear rate potential. Increase resistance to posterior tibial dislocation. Achieve at least 120...
... uni-compartmental knee replacement is an exciting development ... procedure provides patients with a minimally invasive ... the knee often results in severe pain, ... life and even depression. Orthopedic surgeons have ...
... total knee prosthesis stems from many years ... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern ... wear to a minimum. The inherent design ...
Cemented hip system...
Medicine Products: